<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02661646</url>
  </required_header>
  <id_info>
    <org_study_id>5010</org_study_id>
    <nct_id>NCT02661646</nct_id>
  </id_info>
  <brief_title>Quality of Life Changes on Lower Extremity Lymphedema Patients Using an Advanced PCD</brief_title>
  <official_title>Assessment of Quality of Life Changes on Lower Extremity Lymphedema Patients Using an Advanced Pneumatic Compression Device at Home</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tactile Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tactile Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assessment of QOL and symptoms changes in primary or secondary, unilateral or bilateral lower
      extremity patients using an advanced pneumatic compression system.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multi-centered, single arm, observational clinical trial of a prospective cohort of an
      estimated 300 participants with primary or secondary, unilateral or bilateral, lower
      extremity lymphedema. All participants receive intermittent pneumatic compression treatment
      for 52 weeks. Quality of life and symptoms will be assessed pre- and post - intermittent
      pneumatic compression treatment at 12, 24 and 52 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>12 weeks</time_frame>
    <description>Questionnaires to assess quality of life changes after 12 weeks of treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptom changes</measure>
    <time_frame>12 weeks</time_frame>
    <description>Symptom changes after 12 weeks of treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Limb circumference changes after 12 weeks of treatment</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Limb circumference changes after 52 weeks of treatment</measure>
    <time_frame>52 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance</measure>
    <time_frame>Study duration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Skin changes after 12 weeks of treatment</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Skin changes after 52 weeks of treatment</measure>
    <time_frame>52 weeks</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Lymphedema</condition>
  <arm_group>
    <arm_group_label>Advanced Pneumatic Compression Group</arm_group_label>
    <description>All study participants will receive treatment using an advanced pneumatic compression device.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Advanced Pneumatic Compression Device</intervention_name>
    <description>Advanced Pneumatic Compression Device</description>
    <arm_group_label>Advanced Pneumatic Compression Group</arm_group_label>
    <other_name>Flexitouch system</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Primary or secondary, unilateral or bilateral lower extremity lymphedema patients using the
        Flexitouch system during a 12 week study period.

        *Note: Only Veteran's are eligible as this study is run through The Department of Veterans
        Affairs New York Harbor Healthcare System.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 or older

          -  Diagnosis of primary or secondary, unilateral or bilateral lower extremity lymphedema

          -  Ability and willingness to participate in all aspects of the study and ability to
             provide informed consent.

          -  Must have a prescription for the study device

        Exclusion Criteria:

          -  Diagnosis of active or recurrent cancer, or less than 3 months at the time of initial
             evaluation from the completion of chemotherapy, radiation therapy or primary surgery
             for the treatment of cancer.

          -  Diagnosis of acute infection. The source of the infection must be treated for 2 weeks
             prior to admittance into the study.

          -  Acute thrombophlebitis (in last 2 months)

          -  Pulmonary embolism or deep vein thrombosis within the previous 6 months

          -  Pulmonary edema

          -  Class IV congestive heart failure

          -  Patients with poorly controlled asthma

          -  Previous use of the study pneumatic compression device

          -  Currently using multi-layer bandaging

          -  Pregnant women or women of childbearing potential not on contraception

          -  Any condition where increased venous and lymphatic return is undesirable

          -  Currently participating in another clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Maldonado, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jill Christensen</last_name>
    <email>jchristensen@tactilemedical.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elyse Monte</last_name>
    <email>emonte@tactilemedical.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>VA NY Harbor Healthcare System - Brooklyn</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Thomas Maldonado, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VA NY Harbor Healthcare System - St. Albans</name>
      <address>
        <city>Jamaica</city>
        <state>New York</state>
        <zip>11425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Thomas Maldonado, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VA NY Harbor Healthcare System - Manhattan</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Thomas Maldonado, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 18, 2016</study_first_submitted>
  <study_first_submitted_qc>January 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 22, 2016</study_first_posted>
  <last_update_submitted>November 3, 2017</last_update_submitted>
  <last_update_submitted_qc>November 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic Swelling</keyword>
  <keyword>Leg Lymphedema</keyword>
  <keyword>Primary Lymphedema</keyword>
  <keyword>Secondary Lymphedema</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphedema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

